# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875045-19-000041
Filing Date
2019-10-22
Accepted
2019-10-22 16:12:44
Documents
123
Period of Report
2019-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | biib-2019930x10q.htm iXBRL | 10-Q | 3779512
2 | EXHIBIT 10.1 | biib-2019930xex101.htm | EX-10.1 | 9303
3 | EXHIBIT 31.1 | biib-2019930xex311.htm | EX-31.1 | 14191
4 | EXHIBIT 31.2 | biib-2019930xex312.htm | EX-31.2 | 14940
5 | EXHIBIT 32.1 | biib-2019930xex321.htm | EX-32.1 | 10787
11 |  | biogenlogoa05.jpg | GRAPHIC | 62626
12 |  | amortacquiredintangible.jpg | GRAPHIC | 24525
13 |  | biosimilars.jpg | GRAPHIC | 37554
14 |  | reservesfordisandallow.jpg | GRAPHIC | 38904
15 |  | tysabri.jpg | GRAPHIC | 38988
16 |  | tecfidera.jpg | GRAPHIC | 41015
17 |  | equitylossofinvestee.jpg | GRAPHIC | 20723
18 |  | sga.jpg | GRAPHIC | 25498
19 |  | rd.jpg | GRAPHIC | 76754
20 |  | otherincomeexp.jpg | GRAPHIC | 23565
21 |  | interferon.jpg | GRAPHIC | 38590
22 |  | otherrevenues.jpg | GRAPHIC | 33383
23 |  | rdpercentofrev.jpg | GRAPHIC | 43043
24 |  | costofsales.jpg | GRAPHIC | 36332
25 |  | taxprovision.jpg | GRAPHIC | 36067
26 |  | acquiredinprocessrd.jpg | GRAPHIC | 21791
27 |  | lossondivestiture.jpg | GRAPHIC | 20575
28 |  | spinraza.jpg | GRAPHIC | 37054
29 |  | financialhighlights.jpg | GRAPHIC | 37103
30 |  | anticd20.jpg | GRAPHIC | 47839
31 |  | collabprofitshare.jpg | GRAPHIC | 23816
32 |  | gainlossfvcontconsider.jpg | GRAPHIC | 25075
| Complete submission text file | 0000875045-19-000041.txt |  | 18102555

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | biib-20190930.xsd | EX-101.SCH | 73207
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | biib-20190930_cal.xml | EX-101.CAL | 125291
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | biib-20190930_def.xml | EX-101.DEF | 436541
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | biib-20190930_lab.xml | EX-101.LAB | 1053957
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | biib-20190930_pre.xml | EX-101.PRE | 648888
107 | EXTRACTED XBRL INSTANCE DOCUMENT | biib-2019930x10q_htm.xml | XML | 3739209

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 191161860
SIC: 2836 Biological Products, (No Diagnostic Substances)